Track topics on Twitter Track topics that are important to you
"During the third quarter, we made significant progress with our clinical stage programs. We partnered with Vectura to develop Pulmatrix's drug candidate, PUR0200, for chronic
Original Article: Pulmatrix Provides Q3 2017 Highlights and Q3 2017 Updated FinancialsNEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...